Oscar Health, Inc. 2024 Third Quarter Conference Call
NEW YORK--(BUSINESS WIRE)--October 08, 2024--
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2024 financial results before the market opens on Thursday, November 7, 2024.
Management will review these results in a conference call beginning at 8:00 AM $(ET)$. The call-in number and webcast link are as follows:
Live Call: 1.888.596.4244
Conference ID: 7768132
Webcast Link
The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following November 7, 2024 for a period of 90 days.
About Oscar Health
Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.6 million members, as of June 30, 2024.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008350244/en/
CONTACT: Investor:
Chris Potochar
VP of Investor Relations
ir@hioscar.com
Media:
Kristen Prestano
VP of Communications
press@hioscar.com
(END) Dow Jones Newswires
October 08, 2024 08:03 ET (12:03 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.